 |
|
| Blog results | Results 1 - 10 of about 4,973 for neuroendocrine cancer treatment. (0.40 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | My journey thru Neuroendocrine Carcinoma Cancer Hell & Adventures ... - http://www.renalcarcinoid.com/ | |
| 13 Nov 2009 by "Renal Carincoid Guy" >Subscription/Web Site-CancerListing.com is a leading health directory including hematologic, treatment, testing, leukemia, lymphoma, chemotherapy, prevention and treatment, gastrointestinal, prostate cancer, gynecologic cancers and ... My journey thru Neuroendocrine Carcinoma... - http://www.renalcarcinoid.com/ [ More results from My journey thru Neuroendocrine Carcinoma... ] |
| 22 Nov 2009 A study says that radiation therapy can improve longevity in patients with rare pancreatic cancer called pancreatic neuroendocrine tumours (PNTs). The researchers discovered that this technique is successful in achieving local control ... India Server - News - http://www.india-server.com/ |
| 1 Nov 2009 by Cristina One of many forms of cancer is aggressive and devastating neuro-endocrine carcinoma of the colon. The worst feature of this disease is that it is usually detected in advanced stages, at which it is often difficult to treat. ... About cancer - A to Z - http://a-z-cancer.blogspot.com/ |
| 18 Nov 2009 It consists of a CD56-binding antibody with a potent cancer-cell killing agent, DM1, attached to it using an engineered linker. IMGN901 is a potential treatment for MCC, small-cell lung cancer, multiple myeloma, ovarian cancers and other CD56+ tumors. It is in Phase I testing for the treatment ... About Merkel Cell Carcinoma (MCC) MCC is an aggressive neuroendocrine cancer of the skin that typically occurs on the head/neck, most often in individuals of European ancestry. ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 12 Nov 2009 by Bonnie, Original Art Studio Carcinoid tumours are a rare form of neuroendocrine cancer with some peculiar properties. Being related to the neuroendocrine system, they can emit hormones that cause problems (infections, high blood pressure, allergies, blood sugar fluctuations, etc. etc. ... •Recognize the benefits of a team model approach to health care and the collaborative interaction between health care professionals and patients in the assessment and treatment of NeuroEndocrine malignancies. ... Original Art Studio - http://originalartstudio.blogspot.com/ |
| 18 Nov 2009 by Jyotsna Ramani ImmunoGen, Inc (NASDAQ:IMGN) have reported the clinical data of their IMGN901 product candidate which will be used for the treatment of Merkel cell carcinoma. ... 2nd Licensing Deal with Amgen | OneMedPlace » Archive says: 11/22/2009 at 5: 54 pm PST. [...] 1000 to 10000 times more potent than traditional chemotherapy agents. ImmunoGen recently announced favorable Phase I data for IMGN901, its drug candidate for an aggressive neuroendocrine cancer called Merkel cell [...] ... FavStocks - http://www.favstocks.com/ - References [ More results from FavStocks ] |
| 19 Jun 2009 by Tiny Neuroendocrine carcinoma of unknown primary site. Poorly differentiated neuroendocrine carcinoma. REFERENCES . Poorly differentiated neuroendocrine carcinoma of unknown primary site: a newly . ->. poorly differentiated neuroendocrine ... Fashion Resources - http://www.fashion-res.com/ |
| 4 Nov 2009 More research is needed to improve detection and treatment options for patients who develop these kinds of cancer. - Researchers are interested in studying the molecular changes that are involved in endocrine cancer development and ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 16 Nov 2009 by Bogans (Properly speaking, these other cancers should be called "small-cell cancer of the prostate" or "neuroendocrine cancer of the prostate" or something else, rather than "prostate cancer". ... If the cancer grows, or is more aggressive, a patient will typically opt either for surgery (to excise the prostate and allow it to be examined pathologically; radiation remains available as a secondary treatment if the cancer returns) or for primary radiation therapy (to destroy the ... prostate - http://prostate4.blogspot.com/ |
| 9 Oct 2009 by Caring for Carcinoid Foundation What's New in the Treatment of Carcinoid/Neuroendocrine Tumors with Somatostatin Analogs. Edward M. Wolin, M.D.. Co-Director Carcinoid/Neuroendocrine Center Samuel Oschin Comprehensive Cancer Institute Cedars-Sinai Medical Center ... CFCF Research Updates - http://cfcfresearch.blogspot.com/ [ More results from CFCF Research Updates ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
